Dan Li

机构：The University of Texas MD Anderson Cancer Center, Jilin University, Wuhan Puai Hospital, First Hospital of Jilin University, National Clinical Research, Shenzhen Third People’s Hospital · ORCID：0000-0002-5567-6927

发表论文 47 篇 · 总被引 891 次 · h-index 12

代表论文

• Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China (2024 · The Lancet · 被引 111)
• Polyphosphate Kinase Is Required for the Processes of Virulence and Persistence in Acinetobacter baumannii (2022 · Microbiology Spectrum · 被引 25)
• Craniomaxillofacial derived bone marrow mesenchymal stem/stromal cells (BMSCs) for craniomaxillofacial bone tissue engineering: A literature review (2022 · Journal of Stomatology Oral and Maxillofacial Surgery · 被引 19)
• Adipose-derived mesenchymal stem cells with hypoxic preconditioning improve tenogenic differentiation (2022 · Journal of Orthopaedic Surgery and Research · 被引 17)
• Activation and expansion of T-follicular helper cells in chronic lymphocytic leukemia nurselike cell co-cultures (2022 · Leukemia · 被引 16)
• Abnormal glymphatic system function in children with autism spectrum disorder: a diffusion kurtosis imaging study (2025 · European Journal of Pediatrics · 被引 12)